Detalles de la búsqueda
1.
Achieving white blood cell equity: are the safety profiles of biosimilar and reference pegfilgrastims comparable?
Future Oncol
; 20(3): 145-158, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-37609795
2.
Real-world ibrutinib dose reductions, holds and discontinuations in chronic lymphocytic leukemia.
Future Oncol
; 17(35): 4959-4969, 2021 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-34783255
3.
Factors associated with adherence to follow-up calls in cancer patients receiving care at a community oncology practice.
J Oncol Pharm Pract
; 27(5): 1094-1101, 2021 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-32819197
4.
Prevalence and predictors of patients reporting adverse drug reactions to health care providers during oral targeted cancer treatment.
J Am Pharm Assoc (2003)
; 61(1): 53-59, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33032945
5.
A Randomized, Double-Blinded, Phase II Trial of Carboplatin and Pemetrexed with or without Apatorsen (OGX-427) in Patients with Previously Untreated Stage IV Non-Squamous-Non-Small-Cell Lung Cancer: The SPRUCE Trial.
Oncologist
; 24(12): e1409-e1416, 2019 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31420467
6.
The Role of Proteomic Testing in Improving Prognosis And Care Planning Quality Measures for Lung Cancer.
Manag Care
; 26(9): 37-47, 2017 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-29068312
7.
Exceedingly Rare Bilateral Synchronous Germ Cell Testicular Tumors With Different Histopathological Features.
Cureus
; 15(7): e42374, 2023 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-37492037
8.
Soft Tissue Mass Extramedullary Plasmacytoma Following Radiation Therapy for Solitary Bone Plasmacytoma.
Cureus
; 15(8): e43927, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-37614822
9.
Reducing Avoidable Emergency Visits and Hospitalizations With Patient Risk-Based Prescriptive Analytics: A Quality Improvement Project at an Oncology Care Model Practice.
JCO Oncol Pract
; 19(5): e725-e731, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36913643
10.
Biosimilar Use Among 38 ASCO PracticeNET Practices, 2019-2021.
JCO Oncol Pract
; 19(7): 516-522, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37084324
11.
Clinical Outcomes for Plasma-Based Comprehensive Genomic Profiling Versus Standard-of-Care Tissue Testing in Advanced Non-Small Cell Lung Cancer.
Clin Lung Cancer
; 23(1): 72-81, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34782240
12.
Guidance on Implementing an Oral Chemotherapy Drug Repository Program in a Medically Integrated Pharmacy Setting.
JCO Oncol Pract
; 17(7): e448-e453, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33900790
13.
Occupational and Personal Consequences of the COVID-19 Pandemic on US Oncologist Burnout and Well-Being: A Study From the ASCO Clinician Well-Being Task Force.
JCO Oncol Pract
; 17(7): e427-e438, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-34152789
14.
Telehealth in Oncology: ASCO Standards and Practice Recommendations.
JCO Oncol Pract
; 17(9): 546-564, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34319760
15.
Real-world performance of blood-based proteomic profiling in first-line immunotherapy treatment in advanced stage non-small cell lung cancer.
J Immunother Cancer
; 9(10)2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34706885
16.
Nanoparticle Albumin-bound Paclitaxel Plus Carboplatin Induction Followed by Nanoparticle Albumin-bound Paclitaxel Maintenance in Squamous Non-Small-cell Lung Cancer (ABOUND.sqm): A Phase III Randomized Clinical Trial.
Clin Lung Cancer
; 22(1): 6-15.e4, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33097414
17.
Creating a Blueprint of Well-Being in Oncology: An Approach for Addressing Burnout From ASCO's Clinician Well-Being Taskforce.
Am Soc Clin Oncol Educ Book
; 41: e339-e353, 2021 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-34061565
18.
Risk assessment of meat and milk from cloned animals.
Nat Biotechnol
; 25(1): 77-83, 2007 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-17211406
19.
Updates to the ASCO Patient-Centered Oncology Payment Model.
JCO Oncol Pract
; 16(5): 263-269, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32302272
20.
Safety and Efficacy of Nivolumab in Patients With Advanced Clear Cell Renal Cell Carcinoma: Results From the Phase IIIb/IV CheckMate 374 Study.
Clin Genitourin Cancer
; 18(6): 469-476.e4, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32641261